Kyowa Kirin Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KYOWA KIRIN, and what generic alternatives to KYOWA KIRIN drugs are available?
KYOWA KIRIN has two approved drugs.
There are three US patents protecting KYOWA KIRIN drugs.
There are sixty-one patent family members on KYOWA KIRIN drugs in eighteen countries and one supplementary protection certificate in one country.
Drugs and US Patents for Kyowa Kirin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-001 | Aug 27, 2019 | RX | Yes | No | 8,318,201 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-002 | Aug 27, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-002 | Aug 27, 2019 | RX | Yes | Yes | 7,727,993 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-001 | Aug 27, 2019 | RX | Yes | No | 7,727,993 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-001 | Aug 27, 2019 | RX | Yes | No | 7,541,363 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Kyowa Kirin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Kyowa Kirin | FARESTON | toremifene citrate | TABLET;ORAL | 020497-001 | May 29, 1997 | 4,696,949 | ⤷ Sign Up |
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-002 | Aug 27, 2019 | 7,727,994 | ⤷ Sign Up |
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-002 | Aug 27, 2019 | 7,541,363 | ⤷ Sign Up |
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-001 | Aug 27, 2019 | 7,727,994 | ⤷ Sign Up |
Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-001 | Aug 27, 2019 | 7,541,363 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Kyowa Kirin Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 101135917 | ⤷ Sign Up |
Spain | 2384685 | ⤷ Sign Up |
Japan | 2009067807 | ⤷ Sign Up |
European Patent Office | 2942082 | ⤷ Sign Up |
Japan | WO2005030219 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kyowa Kirin Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0095875 | 96C0029 | Belgium | ⤷ Sign Up | PRODUCT NAME: TOREMIFENE; REGISTRATION NO/DATE: EU/1/96/004/001 19960215 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.